Guide gives direction to the last 90

By on .

The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation For almost 35 years, HIV/AIDS has been a household word across the globe. At first a death sentence, HIV has infected 78 million people, killing almost half of them as the world battled it into submission as a treatable, chronic—but still dangerous—condition. […]

Dolutegravir results in low-resource setting highlight benefits

By on .

A standard of care treatment in high-income settings, the benefits of dolutegravir-based treatments for HIV have been clear, with a built-in barrier to the development of drug-resistance, and a less frequent or severe side effects that interfere with staying on a medicine. But the benefits in low-income countries have been harder to assess, with costs, […]

What is data use anyway?

By on .

The following is a guest post by Michelle Li of MEASURE Evaluation At MEASURE Evaluation, funded by the United States Agency for International Development, we work with countries to strengthen health information systems to make changes that improve health for people. And the rationale is this: By implementing health information systems interventions, we improve systems […]

Can counseling, links to services cut death rates in half among people with HIV who inject drugs?

By on .

A study across three countries where HIV incidence is fueled by substance use found that a little support went a long way for people living with the virus and injecting drugs — helping them to stay on antiretroviral treatment and opioid substitution therapy, and keep their viral levels suppressed. The study, at health centers in […]

Yellow fever patient in Republic of Congo prompts outbreak declaration, response

By on .

Republic of Congo health officials are calling risks to public health at a national level high, and at a regional level moderate, after confirmation that a man was infected with yellow fever in a city densely populated with about a million people, as well as with mosquitos capable of spreading the virus, according to a […]

Delamanid delay comes home

By on .

Patient benefits from access to innovative drug that still awaits U.S. approval A note from the field in this week’s Morbidity and Mortality Weekly Report describes the case of a dangerously ill man in the United States. Weak, coughing, and losing weight, with pain in his chest, he was tested for tuberculosis, which it turned […]

Signs of Ebola control, cautious optimism reflect lessons, missed opportunities, continuing gaps

By on .

More than two million travelers checked at 37 points of entry — airports, river ports, and border crossings —  between the Democratic Republic of Congo and neighboring countries. More than six thousand people who had contact with the sick, including health workers, or with others who had contact with them, vaccinated. Three different investigational treatment […]

What we’re reading: Changes needed to stop Ebola, other threats of pan-epidemic potential

By on .

Health-care worker infections add to Ebola challenge in Congo – The challenges arising when a new Ebola outbreak surfaces in an area where the virus hasn’t been seen before include the exposure of frontline health workers without experience in necessary detection and protection measures. The resulting infections among medical staff who are needed most and […]

TB treatment trial aims to consign lengthier, more toxic regimens to history

By on .

With the enrollment of its first patients in Eastern Europe, the largest trial yet to test a four-drug, four-month treatment regimen against tuberculosis will set out to demonstrate whether fewer medicines, over a shorter length of time can cure nearly all TB patients. The trial, which will launch in Tbilisi, the capital of the country of […]